<code id='E8CB617925'></code><style id='E8CB617925'></style>
    • <acronym id='E8CB617925'></acronym>
      <center id='E8CB617925'><center id='E8CB617925'><tfoot id='E8CB617925'></tfoot></center><abbr id='E8CB617925'><dir id='E8CB617925'><tfoot id='E8CB617925'></tfoot><noframes id='E8CB617925'>

    • <optgroup id='E8CB617925'><strike id='E8CB617925'><sup id='E8CB617925'></sup></strike><code id='E8CB617925'></code></optgroup>
        1. <b id='E8CB617925'><label id='E8CB617925'><select id='E8CB617925'><dt id='E8CB617925'><span id='E8CB617925'></span></dt></select></label></b><u id='E8CB617925'></u>
          <i id='E8CB617925'><strike id='E8CB617925'><tt id='E8CB617925'><pre id='E8CB617925'></pre></tt></strike></i>

          explore

          explore

          author:entertainment    Page View:65618
          Alastair Grant/AP

          LONDON — AstraZeneca said Tuesday it would acquire Fusion Pharmaceuticals in a deal worth more than $2 billion, picking up a company focused on the booming area of targeted radiation therapies for cancer.

          AstraZeneca will pay $2 billion in cash upfront for Fusion, a price that at $21 a share is nearly double Fusion’s closing share price on Monday. If certain regulatory milestones are met, AstraZeneca will pay another $3 a share, or roughly $400 million.

          advertisement

          Fusion specializes in developing radiopharmaceuticals, also known as radioconjugates or radioligands, which deliver radiation directly to tumors, guided by particular markers on cancer cells. The aim is not only to minimize the risk of damaging surrounding, healthy tissue, but also to reach tumors that traditional radiation can’t. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          'Of course' Trump lost the 2020 election, DeSantis says after years of hedging
          'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

          5:06RepublicanpresidentialcandidateFloridaGov.RonDeSantisspeaksduringafundraisingeventforU.S.Rep.Ash

          read more
          Sports medicine is finally prioritizing gender equality
          Sports medicine is finally prioritizing gender equality

          MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

          read more

          Choosing scientific sides in the fight against Alzheimer's

          MollyFergusonforSTATIn1906,Dr.AloisAlzheimerworkedwithapatientnamedAugustD.,awomanwithextremememoryl